On June 5, 2023, Telesis Bio, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.53 USD | -8.55% | -17.01% | -49.74% |
May. 09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
May. 09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.74% | 6.46M | |
+10.95% | 226B | |
+14.81% | 198B | |
+19.77% | 142B | |
+30.52% | 111B | |
+2.09% | 65.26B | |
+16.41% | 54.36B | |
+4.96% | 50.94B | |
+9.47% | 44.8B | |
+4.23% | 36.8B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio, Inc. announced that it has received $28 million in funding from Novalis Capital Partners LLC, Northpond Ventures, LLC, BroadOak Capital Partners LLC, Investment Arm and another investor